ArticleDermatology and therapy2024

Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.

Ashley Wysong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.